“These data present important challenges that require a multifactorial approach on the part of physicians and their patients,” said Benjamin Fiedler. “These methods should include changes in therapeutic lifestyles, adjuvant pharmacological treatments and detection.”
Therapeutic changes in proven lifestyle include avoiding and treating overweight and obesity, as well as regular physical activity and adjuvant pharmacotherapy, including aspirin.
“It has played an important role in reducing premature deaths from heart attacks and strokes,” said Henkins, who conducted pioneering research on the benefits of cholesterol-lowering drugs, aspirin, angiotensin-converting enzyme inhibitors. (ACE), angiotensin receptor blockers (ARB) and beta-adrenergic blockers.
Hynkins was the first to demonstrate that aspirin significantly reduces a first heart attack, as well as frequent heart attacks, strokes and cardiovascular death when administered within 24 hours after the onset of heart attack symptoms, as well as a wide range of range of patients who have survived heart blocks. . His discoveries and first discoveries about aspirin are not limited to cardiovascular diseases and include the prevention of recurrent migraines. Previous data in the monitoring study also suggested vexgen keto that aspirin may reduce the risk of colorectal cancer and delay cognitive loss, as well as reduce the development of type 2 diabetes. Since then, randomized trials and meta-analyzes have indicated that Aspirin inhibits colorectal cancer tumors and colorectal cancer.
“More than 90 percent of patients diagnosed with colorectal cancer are age 50 or older.” The main risk factors are similar to those of heart attacks and strokes: overweight and obesity, as well as physical inactivity, diet low in fiber and high in fat, “said Lawrence. Fiedler, MD, as well as type 2 diabetes
According to the US Centers for Disease Control and Prevention. U.S., Additional risk factors include inflammatory bowel disease, such as Crohn’s disease or ulcerative colitis. Personal or family history of colorectal cancer or benign polyps. The genetic syndrome, such as familial glandular disease or colorectal cancer, is not polyposis (Lynch syndrome).